KeyBank National Association’s Anixa Biosciences ANIX Stock Holding History

KeyBank National Association’s Portfolio ANIX Stock Details ANIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$44.3K	Hold	15,810	–	–	﹤0.01%	1308
2026 Q1	$40.8K	Hold	15,810	–	–	﹤0.01%	1233
2025 Q4	$49.3K	Buy	15,810 +300	+2%	+$1.23K	﹤0.01%	1191
2025 Q3	$51.2K	Hold	15,510	–	–	﹤0.01%	1172
2025 Q2	$51.2K	Hold	15,510	–	–	﹤0.01%	1158
2025 Q1	$44.4K	Hold	15,510	–	–	﹤0.01%	1143
2024 Q4	$36K	Hold	15,510	–	–	﹤0.01%	1151
2024 Q3	$48.9K	Hold	15,510	–	–	﹤0.01%	1125
2024 Q2	$34.3K	Hold	15,510	–	–	﹤0.01%	1085
2024 Q1	$48.4K	Hold	15,510	–	–	﹤0.01%	1078
2023 Q4	$60.2K	Hold	15,510	–	–	﹤0.01%	1066
2023 Q3	$50.7K	Hold	15,510	–	–	﹤0.01%	1019
2023 Q2	$49.6K	Hold	15,510	–	–	﹤0.01%	1045
2023 Q1	$66.7K	Hold	15,510	–	–	﹤0.01%	1040
2022 Q4	$65.9K	Hold	15,510	–	–	﹤0.01%	1039
2022 Q3	$76K	Hold	15,510	–	–	﹤0.01%	1021
2022 Q2	$47K	Hold	15,510	–	–	﹤0.01%	1051
2022 Q1	$42K	Buy	+15,510	New	+$45.5K	﹤0.01%	1063

Other funds holding ANIX

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

LNWTC

Laird Norton Wetherby Trust Company Seattle, Washington $5.21B AUM 31.48% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

KeyBank National Association's ANIX Position: Q2 2026 in Review

KeyBank National Association held its Anixa Biosciences (ANIX) position steady in Q2 2026 at 15,810 shares worth $44.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1308.

KeyBank National Association first reported a position in ANIX in Q1 2022 and has held it in 18 quarters since. The position peaked at $76K in Q3 2022. 63 funds tracked by Wall St. Rank hold ANIX as of Q2 2026.

KeyBank National Association held 15,810 shares of Anixa Biosciences worth $44.3K as of Q2 2026.
KeyBank National Association left its Anixa Biosciences share count unchanged in Q2 2026.
Anixa Biosciences made up ﹤0.01% of KeyBank National Association's portfolio in Q2 2026, its #1308 holding.
KeyBank National Association first reported a position in Anixa Biosciences in Q1 2022 and has held it in 18 quarters since.
KeyBank National Association's Anixa Biosciences position peaked at $76K in Q3 2022.
63 funds tracked by Wall St. Rank held Anixa Biosciences as of Q2 2026.

Based on KeyBank National Association's 13F filing for Q2 2026, filed 28 Jul 2026.